← Dashboard
Stock
THC
TENET HEALTHCARE CORPHealth CareHealth Care FacilitiesLatest close $1929 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
9
27 funds tracked
Ever held
15
Current + past
New this quarter
0
Exited this quarter
1
Marquee-fund ownership over time
Aug 14, 2013Feb 13, 2019Nov 10, 2022May 15, 2026
Now
9
This quarter's activity
New positions opened
None.
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Glenview Capital | Q3 2013 | 52Q | $41 | $192 | +364% |
| Bridgewater Associates re-entered | Q4 2013 | 51Q | $43 | $192 | +343% |
| Greenlight Capital | Q1 2023 | 13Q | $62 | $192 | +211% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $154 | $192 | +25% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $154 | $192 | +25% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $154 | $192 | +25% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $154 | $192 | +25% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $154 | $192 | +25% |
| Lone Pine Capital | Q1 2026 | 1Q | $234 | $192 | -18% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Point72 Asset Management 2× in & out | Q2 2025 | Q2 2026 | → $197 | +20% |
| Maverick Capital 7× in & out | Q3 2024 | Q4 2025 | → $193 | +25% |
| Renaissance Technologies | Q3 2024 | Q3 2025 | → $172 | +15% |
| Viking Global Investors 3× in & out | Q3 2023 | Q1 2024 | → $88 | +20% |
| Elliott Management 2× in & out | Q1 2017 | Q2 2017 | → $18 | -5% |
| Appaloosa | Q2 2016 | Q3 2016 | → $26 | -10% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at TENET HEALTHCARE CORP. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
23
Filings · last 90d
31
Total on file
549
Recent SEC buffer
Most recent
May 29, 2026
30d / 90d windows measured from May 29, 2026 — the most recent Form 4 on file — not from today.
- Form 40001193125-26-249167May 29, 2026
- Form 40001193125-26-245814May 28, 2026
- Form 40001193125-26-245813May 28, 2026
- Form 40001193125-26-245812May 28, 2026
- Form 40001193125-26-245811May 28, 2026
- Form 40001193125-26-245810May 28, 2026
- Form 40001193125-26-245809May 28, 2026
- Form 40001193125-26-245808May 28, 2026
- Form 40001193125-26-245807May 28, 2026
- Form 40001193125-26-245806May 28, 2026
- Form 40001193125-26-245805May 28, 2026
- Form 40001193125-26-245804May 28, 2026
- Form 40001193125-26-239943May 26, 2026
- Form 40001193125-26-239942May 26, 2026
- Form 40001193125-26-239941May 26, 2026
Showing 15 of 549 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · TENET HEALTHCARE CORPAnnual figures sourced directly from TENET HEALTHCARE CORP's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$21.31B
FY2025+3% YoY
Net income
$1.12B
FY2010+500%+ YoY
EPS (diluted)
$15.49
FY2025-53% YoY
Free cash flow(?)
$2.53B
FY2025+127% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for TENET HEALTHCARE CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 29, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KMaterial eventApr 30, 2026
- DEF 14AProxy statementApr 16, 2026
- 8-KMaterial eventApr 10, 2026
- 8-KMaterial eventMar 30, 2026
- 10-KAnnual reportFeb 17, 2026
- 8-KMaterial eventFeb 11, 2026
- 8-KMaterial eventFeb 2, 2026
- 8-KMaterial eventNov 24, 2025
- 8-KMaterial eventNov 18, 2025
- 8-KMaterial eventNov 5, 2025
- 8-KMaterial eventNov 3, 2025
- 10-QQuarterly reportOct 28, 2025
- 8-KMaterial eventOct 28, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Lone Pine Capital | Q1 2026 | open | $234 | $163 | -30% |
| Point72 Asset Management | Q2 2025 | Q2 2026 | $164 | $197 | +20% |
| Citadel Advisors | Q3 2024 | open | $154 | $192 | +25% |
| Two Sigma Investments | Q3 2024 | open | $154 | $192 | +25% |
| D.E. Shaw | Q3 2024 | open | $154 | $192 | +25% |
| AQR Capital Management | Q3 2024 | open | $154 | $192 | +25% |
| Millennium Management | Q3 2024 | open | $154 | $192 | +25% |
| Maverick Capital | Q3 2024 | Q4 2025 | $154 | $193 | +25% |
| Point72 Asset Management | Q3 2024 | Q1 2025 | $154 | $133 | -13% |
| Renaissance Technologies | Q3 2024 | Q3 2025 | $150 | $172 | +15% |
| Viking Global Investors | Q3 2023 | Q1 2024 | $73 | $88 | +20% |
| Greenlight Capital | Q1 2023 | open | $62 | $192 | +211% |
| Viking Global Investors | Q4 2022 | Q1 2023 | $42 | $62 | +48% |
| Maverick Capital | Q4 2022 | Q2 2024 | $42 | $133 | +218% |
| Bridgewater Associates | Q4 2022 | open | $42 | $163 | +285% |
| Bridgewater Associates | Q3 2021 | Q1 2022 | $70 | $81 | +16% |
| Viking Global Investors | Q2 2021 | Q3 2022 | $65 | $67 | +2% |
| Maverick Capital | Q4 2020 | Q2 2022 | $32 | $71 | +123% |
| Maverick Capital | Q2 2020 | Q3 2020 | $17 | $29 | +69% |
| Maverick Capital | Q4 2019 | Q1 2020 | $29 | $33 | +13% |
| Maverick Capital | Q2 2019 | Q3 2019 | $21 | $20 | -6% |
| Bridgewater Associates | Q1 2019 | Q2 2019 | $24 | $20 | -13% |
| Bridgewater Associates | Q2 2018 | Q4 2018 | $33 | $24 | -28% |
| Maverick Capital | Q2 2018 | Q3 2018 | $33 | $33 | +0% |
| Elliott Management | Q1 2017 | Q2 2017 | $19 | $18 | -5% |
| Appaloosa | Q2 2016 | Q3 2016 | $28 | $26 | -10% |
| Bridgewater Associates | Q4 2015 | Q1 2016 | $31 | $23 | -26% |
| Elliott Management | Q2 2015 | Q3 2015 | $48 | $52 | +8% |
| Bridgewater Associates | Q4 2013 | Q4 2014 | $43 | $48 | +11% |
| Glenview Capital | Q3 2013 | open | $41 | $192 | +364% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.